Abstract
Interleukin-6 (IL-6) has an important role in the pathogenesis of chronic viral hepatitis and related liver diseases. Although host genetics associated with the response to anti-viral treatment have been reported, little is known about the relationship between IL6 genetic polymorphisms and the outcome of hepatitis B virus (HBV) infection. In this study, we determined the genotype distribution of rs1800796 polymorphism in healthy controls and cases including chronic HBV (CHB), hepatitis C virus and HIV infection. The rs1800796 was found to be associated with clinical outcome of CHB in experimental and validation cohort. The rs1800796C allele has twofold higher promoter activity than G allele. Consistently, CD14+ monocytes from subjects carrying the rs1800796C allele produced more IL-6 in response to in vitro HBV core antigen stimulation than those carrying G allele. Moreover, CHB patients carrying rs1800796C allele have significantly higher T-helper 17 (Th17) and regulatory T cell (Treg) ratio. Finally, a transcription factor C/EBPα binds in higher affinity to rs1800796C allele than to G allele. These results suggest that genetic predisposition to higher IL-6 production is associated with increased risk to HBV infection and hepatic inflammation, which might be due to C/EBPα-mediated regulatory effect on Th17 and Treg responses. Appropriate manipulation of IL-6 expression might be used to prevent and treat HBV infection.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout




Similar content being viewed by others
References
Liang X, Bi S, Yang W, Wang L, Cui G, Cui F et al. Epidemiological serosurvey of hepatitis B in China–declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009; 27: 6550–6557.
Lu FM, Zhuang H . Management of hepatitis B in China. Chin Med J (Engl) 2009; 122: 3–4.
Chen CJ, Yang HI . Natural history of chronic hepatitis B REVEALed. J Gastroenterol Hepatol 2011; 26: 628–638.
Hann HW, Kim CY, London WT, Whitford P, Blumberg BS . Hepatitis B virus and primary hepatocellular carcinoma: family studies in Korea. Int J Cancer 1982; 30: 47–51.
Lin TM, Chen CJ, Wu MM, Yang CS, Chen JS, Lin CC et al. Hepatitis B virus markers in Chinese twins. Anticancer Res 1989; 9: 737–741.
Li N, Gao YF, Zhang TC, Chen P, Li X, Su F . Relationship between interleukin 18 polymorphisms and susceptibility to chronic hepatitis B virus infection. World J Hepatol 2012; 4: 105–109.
Thursz M, Yee L, Khakoo S . Understanding the host genetics of chronic hepatitis B and C. Semin Liver Dis 2011; 31: 115–127.
Li W, Jiang Y, Jin Q, Shi X, Jin J, Gao Y et al. Expression and gene polymorphisms of interleukin 28B and hepatitis B virus infection in a Chinese Han population. Liver Int 2011; 31: 1118–1126.
Deng G, Zhou G, Zhang R, Zhai Y, Zhao W, Yan Z et al. Regulatory polymorphisms in the promoter of CXCL10 gene and disease progression in male hepatitis B virus carriers. Gastroenterology 2008; 134: 716–726.
Thursz MR, Kwiatkowski D, Allsopp CE, Greenwood BM, Thomas HC, Hill AV . Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med 1995; 332: 1065–1069.
Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi A, Hosono N et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 2009; 41: 591–595.
Guo X, Zhang Y, Li J, Ma J, Wei Z, Tan W et al. Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population. Hepatology 2011; 53: 422–428.
Guo X, Zhang Y, Li J, Ma J, Wei Z, Tan W et al. Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population. Hepatology 2011; 53: 422–428.
Johnson C, Han Y, Hughart N, McCarra J, Alpini G, Meng F . Interleukin-6 and its receptor, key players in hepatobiliary inflammation and cancer. Transl Gastrointest Cancer 2012; 1: 58–70.
Dienz O, Rincon M . The effects of IL-6 on CD4 T cell responses. Clin Immunol 2009; 130: 27–33.
Rantala A, Lajunen T, Juvonen R, Paldanius M, Silvennoinen-Kassinen S, Peitso A et al. Interleukin-6-174 G/C promoter polymorphism is associated with persistence of Chlamydia pneumoniae antibodies in young men. Scand J Immunol 2011; 74: 95–99.
Cussigh A, Falleti E, Fabris C, Bitetto D, Cmet S, Fontanini E et al. Interleukin 6 promoter polymorphisms influence the outcome of chronic hepatitis C. Immunogenetics 2010; 63: 33–41.
Zhang G, Zhou B, Wang W, Zhang M, Zhao Y, Wang Z et al. A functional single-nucleotide polymorphism in the promoter of the gene encoding interleukin 6 is associated with susceptibility to tuberculosis. J Infect Dis 2012; 205: 1697–1704.
Martin-Loeches I, Sole-Violan J, Rodriguez de Castro F, Garcia-Laorden MI, Borderias L, Blanquer J et al. Variants at the promoter of the interleukin-6 gene are associated with severity and outcome of pneumococcal community-acquired pneumonia. Intensive Care Med 2012; 38: 256–262.
Lu Y, Peng J, Wang C, Zhu Y, Wang F, Sun Z . IL-6 promoter functional polymorphism -572C/G affects spontaneous clearance of hepatitis B virus infection. Clin Lab 2014; 60: 1903–1907.
Tang S, Yuan Y, He Y, Pan D, Zhang Y, Liu Y et al. Genetic polymorphism of interleukin-6 influences susceptibility to HBV-related hepatocellular carcinoma in a male Chinese Han population. Hum Immunol 2014; 75: 297–301.
Terry CF, Loukaci V, Green FR . Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 2000; 275: 18138–18144.
Li J, Qiu SJ, She WM, Wang FP, Gao H, Li L et al. Significance of the balance between regulatory T (Treg) and T helper 17 (Th17) cells during Hepatitis B Virus related liver fibrosis. PLoS One 2012; 7: e39307.
Zhang JY, Song CH, Shi F, Zhang Z, Fu JL, Wang FS . Decreased ratio of Treg cells to Th17 cells correlates with HBV DNA suppression in chronic hepatitis B patients undergoing entecavir treatment. PLoS One 2010; 5: e13869.
Xue-Song L, Cheng-Zhong L, Ying Z, Mo-Bin W . Changes of Treg and Th17 cells balance in the development of acute and chronic hepatitis B virus infection. BMC Gastroenterol 2012; 12: 43.
Niu Y, Liu H, Yin D, Yi R, Chen T, Xue H et al. The balance between intrahepatic IL-17(+) T cells and Foxp3(+) regulatory T cells plays an important role in HBV-related end-stage liver disease. BMC Immunol 2011; 12: 47.
Zheng Y, Huang Z, Chen X, Tian Y, Tang J, Zhang Y et al. Effects of telbivudine treatment on the circulating CD4(+) T-cell subpopulations in chronic hepatitis B patients. Mediators Inflamm 2012; 2012: 789859.
Barrett S, Collins M, Kenny C, Ryan E, Keane CO, Crowe J . Polymorphisms in tumour necrosis factor-alpha, transforming growth factor-beta, interleukin-10, interleukin-6, interferon-gamma, and outcome of hepatitis C virus infection. J Med Virol 2003; 71: 212–218.
Falleti E, Fabris C, Vandelli C, Colletta C, Cussigh A, Smirne C et al. Genetic polymorphisms of interleukin-6 modulate fibrosis progression in mild chronic hepatitis C. Hum Immunol 2010; 71: 999–1004.
Migita K, Miyazoe S, Maeda Y, Daikoku M, Abiru S, Ueki T et al. Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection–association between TGF-beta1 polymorphisms and hepatocellular carcinoma. J Hepatol 2005; 42: 505–510.
Ben-Ari Z, Mor E, Papo O, Kfir B, Sulkes J, Tambur AR et al. Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am J Gastroenterol 2003; 98: 144–150.
Li C, Zhi-Xin C, Li-Juan Z, Chen P, Xiao-Zhong W . The association between cytokine gene polymorphisms and the outcomes of chronic HBV infection. Hepatol Res 2006; 36: 158–166.
Ribeiro CS, Visentainer JE, Moliterno RA . Association of cytokine genetic polymorphism with hepatitis B infection evolution in adult patients. Mem Inst Oswaldo Cruz 2007; 102: 435–440.
Cox ED, Hoffmann SC, DiMercurio BS, Wesley RA, Harlan DM, Kirk AD et al. Cytokine polymorphic analyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin-6. Transplantation 2001; 72: 720–726.
Meenagh A, Williams F, Ross OA, Patterson C, Gorodezky C, Hammond M et al. Frequency of cytokine polymorphisms in populations from western Europe, Africa, Asia, the Middle East and South America. Hum Immunol 2002; 63: 1055–1061.
Fabris C, Toniutto P, Bitetto D, Fattovich G, Falleti E, Fontanini E et al. Gene polymorphism at the interleukin 6 -174 G>C locus affects the outcome of chronic hepatitis B. J Infect 2009; 59: 144–145.
Moran DM, Mayes N, Koniaris LG, Cahill PA, McKillop IH . Interleukin-6 inhibits cell proliferation in a rat model of hepatocellular carcinoma. Liver Int 2005; 25: 445–457.
Di Bisceglie AM, Lyra AC, Schwartz M, Reddy RK, Martin P, Gores G et al. Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status. Am J Gastroenterol 2003; 98: 2060–2063.
Sievert W, Altraif I, Razavi HA, Abdo A, Ahmed EA, Alomair A et al. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int 2011; 31: 61–80.
Shepard CW, Finelli L, Alter MJ . Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005; 5: 558–567.
Shah A, Silverstein PS, Kumar S, Singh DP, Kumar A . Synergistic cooperation between methamphetamine and HIV-1 gsp120 through the P13K/Akt pathway induces IL-6 but not IL-8 expression in astrocytes. PLoS One 2012; 7: e52060.
Iloeje UH, Yang HI, Chen CJ . Natural history of chronic hepatitis B: what exactly has REVEAL Revealed? Liver Int 2012; 32: 1333–1341.
Zhang JY, Zhang Z, Lin F, Zou ZS, Xu RN, Jin L et al. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 2010; 51: 81–91.
Zhang F, Yao S, Yuan J, Zhang M, He Q, Yang G et al. Elevated IL-6 receptor expression on CD4+ T cells contributes to the increased Th17 responses in patients with chronic hepatitis B. Virol J 2011; 8: 270.
Wu W, Li J, Chen F, Zhu H, Peng G, Chen Z . Circulating Th17 cells frequency is associated with the disease progression in HBV infected patients. J Gastroenterol Hepatol 2010; 25: 750–757.
Mackey SL, Darlington GJ . CCAAT enhancer-binding protein alpha is required for interleukin-6 receptor alpha signaling in newborn hepatocytes. J Biol Chem 2004; 279: 16206–16213.
Chinese Society of Hepatology, Chinese Medical Association Chinese Society of Infectious Diseases, Chinese Medical Association. Guideline on prevention and treatment of chronic hepatitis B in China (2005). Chin Med J (Engl) 2007; 120: 2159–2173.
Chinese Medical Association Chinese Center for Disease Control and Prevention. Guidelines for diagnosis and treatment of HIV/AIDS in China (2005). Chin Med J (Engl) 2006; 119: 1589–1608.
Hepatotogy Branch, Infectious and Parasitology Branch, Chinese Medical Association. [Guideline of prevention and treatment of hepatitis C]. Zhonghua Yu Fang Yi Xue Za Zhi 2004; 38: 210–215.
Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association. [The guideline of prevention and treatment for chronic hepatitis B (2010 version)]. Zhonghua Gan Zang Bing Za Zhi 2011; 19: 13–24.
Chen X, Zhang M, Liao M, Graner MW, Wu C, Yang Q et al. Reduced Th17 response in patients with tuberculosis correlates with IL-6 R expression on CD4+ T Cells. Am J Respir Crit Care Med 2010; 181: 734–742.
Fazekas de St Groth B, Zhu E, Asad S, Lee L . Flow cytometric detection of human regulatory T cells. Methods Mol Biol 2011; 707: 263–279.
Revzin A . Gel electrophoresis assays for DNA-protein interactions. BioTechniques 1989; 7: 346–355.
Acknowledgements
This study was supported by Natural Science Foundation of China (numbers 81172732 and 81501714); Guangdong Key Laboratory of Emerging Infectious Diseases; Natural Science Foundation of Guangdong (number 2014A030313789); Shenzhen Key Laboratory of Infection and Immunity; and Shenzhen Scientific and Technological Foundation (number JCYJ20140411111 718166). We thank staffs, doctors and nurses of Shenzhen Third People’s Hospital for patient management, sample collection and analysis in this work.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Zhang, G., Wang, W., Li, S. et al. IL6 gene allele-specific C/EBPα-binding activity affects the development of HBV infection through modulation of Th17/Treg balance. Genes Immun 16, 528–535 (2015). https://doi.org/10.1038/gene.2015.40
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/gene.2015.40
This article is cited by
-
A proline deletion in IFNAR1 impairs IFN-signaling and underlies increased resistance to tuberculosis in humans
Nature Communications (2018)


